Lataa...
Immunogenicity Assessment of Lipegfilgrastim in Patients with Breast Cancer Receiving Chemotherapy
Lipegfilgrastim is a long-acting, once-per-cycle, glycopegylated recombinant granulocyte colony-stimulating factor (G-CSF) used to prevent neutropenia in patients receiving myelosuppressive chemotherapy. This integrated analysis examined the immunogenicity of lipegfilgrastim and its potential clinic...
Tallennettuna:
| Julkaisussa: | J Immunol Res |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi Publishing Corporation
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4935921/ https://ncbi.nlm.nih.gov/pubmed/27419145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/9248061 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|